These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34575403)

  • 1. Targeting Tumor Cells with Nanoparticles for Enhanced Co-Drug Delivery in Cancer Treatment.
    Huang WY; Lai CH; Peng SL; Hsu CY; Hsu PH; Chu PY; Feng CL; Lin YH
    Pharmaceutics; 2021 Aug; 13(9):. PubMed ID: 34575403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-Delivery of Natural Compounds with a Dual-Targeted Nanoparticle Delivery System for Improving Synergistic Therapy in an Orthotopic Tumor Model.
    Chu PY; Tsai SC; Ko HY; Wu CC; Lin YH
    ACS Appl Mater Interfaces; 2019 Jul; 11(27):23880-23892. PubMed ID: 31192580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3-gallate.
    Ray L; Kumar P; Gupta KC
    Biomaterials; 2013 Apr; 34(12):3064-76. PubMed ID: 23357370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Chemotherapeutic Efficacy of PLGA-Encapsulated Epigallocatechin Gallate (EGCG) Against Human Lung Cancer.
    Zhang L; Chen W; Tu G; Chen X; Lu Y; Wu L; Zheng D
    Int J Nanomedicine; 2020; 15():4417-4429. PubMed ID: 32606686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate decorated epigallocatechin-3-gallate (EGCG) loaded PLGA nanoparticles; in-vitro and in-vivo targeting efficacy against MDA-MB-231 tumor xenograft.
    Kazi J; Sen R; Ganguly S; Jha T; Ganguly S; Chatterjee Debnath M
    Int J Pharm; 2020 Jul; 585():119449. PubMed ID: 32464231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with doxorubicin-loaded galactosylated poly(ethyleneglycol)-lithocholic acid to suppress the tumor growth in an orthotopic mouse model of liver cancer.
    Singh B; Jang Y; Maharjan S; Kim HJ; Lee AY; Kim S; Gankhuyag N; Yang MS; Choi YJ; Cho MH; Cho CS
    Biomaterials; 2017 Feb; 116():130-144. PubMed ID: 27914985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-targeting hybrid nanoparticles for the delivery of SN38 to Her2 and CD44 overexpressed human gastric cancer.
    Yang Z; Luo H; Cao Z; Chen Y; Gao J; Li Y; Jiang Q; Xu R; Liu J
    Nanoscale; 2016 Jun; 8(22):11543-58. PubMed ID: 27203688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional nanoparticles for targeting the tumor microenvironment to improve synergistic drug combinations and cancer treatment effects.
    Chen ML; Lai CJ; Lin YN; Huang CM; Lin YH
    J Mater Chem B; 2020 Dec; 8(45):10416-10427. PubMed ID: 33112350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD-L1 monoclonal antibody-conjugated nanoparticles enhance drug delivery level and chemotherapy efficacy in gastric cancer cells.
    Xu S; Cui F; Huang D; Zhang D; Zhu A; Sun X; Cao Y; Ding S; Wang Y; Gao E; Zhang F
    Int J Nanomedicine; 2019; 14():17-32. PubMed ID: 30587982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active Tumor-Targeted co-Delivery of Epigallocatechin Gallate and Doxorubicin in Nanoparticles for Combination Gastric Cancer Therapy.
    Mi FL; Wang LF; Chu PY; Peng SL; Feng CL; Lai YJ; Li JN; Lin YH
    ACS Biomater Sci Eng; 2018 Aug; 4(8):2847-2859. PubMed ID: 33435008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin and adjudin co-loaded pH-sensitive nanoparticles for the treatment of drug-resistant cancer.
    Wang Q; Zou C; Wang L; Gao X; Wu J; Tan S; Wu G
    Acta Biomater; 2019 Aug; 94():469-481. PubMed ID: 31141733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted drug delivery of near IR fluorescent doxorubicin-conjugated poly(ethylene glycol) bisphosphonate nanoparticles for diagnosis and therapy of primary and metastatic bone cancer in a mouse model.
    Rudnick-Glick S; Corem-Salkmon E; Grinberg I; Margel S
    J Nanobiotechnology; 2016 Dec; 14(1):80. PubMed ID: 27919267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer.
    Zhu D; Tao W; Zhang H; Liu G; Wang T; Zhang L; Zeng X; Mei L
    Acta Biomater; 2016 Jan; 30():144-154. PubMed ID: 26602819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual targeting smart drug delivery system for multimodal synergistic combination cancer therapy with reduced cardiotoxicity.
    Shubhra QTH; Guo K; Liu Y; Razzak M; Serajum Manir M; Moshiul Alam AKM
    Acta Biomater; 2021 Sep; 131():493-507. PubMed ID: 34139367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Development of Hyaluronan/Fucoidan-Based Nanoparticles as Macrophages Targeting an Epigallocatechin-3-Gallate Delivery System.
    Ho CH; Chu PY; Peng SL; Huang SC; Lin YH
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32878305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying synergistic combinations of Doxorubicin-Loaded polyquercetin nanoparticles and natural Products: Implications for breast cancer therapy.
    Sunoqrot S; Abusulieh S; Abusara OH
    Int J Pharm; 2023 Oct; 645():123392. PubMed ID: 37683979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotheranostics With the Combination of Improved Targeting, Therapeutic Effects, and Molecular Imaging.
    Peng SL; Lai CH; Chu PY; Hsieh JT; Tseng YC; Chiu SC; Lin YH
    Front Bioeng Biotechnol; 2020; 8():570490. PubMed ID: 33042972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Codelivery of salinomycin and docetaxel using poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles to target both gastric cancer cells and cancer stem cells.
    Li L; Cui D; Ye L; Li Y; Zhu L; Yang L; Bai B; Nie Z; Gao J; Cao Y
    Anticancer Drugs; 2017 Oct; 28(9):989-1001. PubMed ID: 28692437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-delivery of Doxorubicin and D-α-Tocopherol Polyethylene Glycol 1000 Succinate by Magnetic Nanoparticles.
    Metin E; Mutlu P; Gündüz U
    Anticancer Agents Med Chem; 2018; 18(8):1138-1147. PubMed ID: 29532763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of arginine-glycine-aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization.
    Chang CY; Wang MC; Miyagawa T; Chen ZY; Lin FH; Chen KH; Liu GS; Tseng CL
    Int J Nanomedicine; 2017; 12():279-294. PubMed ID: 28115846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.